17Dec 2022
Coronary microvascular disease: The “Meeting Point” of Cardiology, Rheumatology and Endocrinology

Coronary microvascular disease: The “Meeting Point” of Cardiology, Rheumatology and Endocrinology

CMD is a multifactorial disease leading to myocardial ischemia/fibrosis alone or in combination with epicardial coronary artery disease. Endothelial dysfunction/vasospasm, systemic inflammation, and/or neuroendocrine activation may act as causative factors and bring Cardiology, Rheumatology and Endocrinology together. Currently, the application of advanced imaging modalities, and specifically CMR, allows reliable assessment of the extent and severity of CMD. These measurements should not be limited to “pure cardiac patients”, as it is known that CMD affects the majority of patients with autoimmune rheumatic and endocrine/metabolic disorders.

  • #cardiology

Like

Save

Share